ArticleNature communications2026
Mesoscale proximity labeling at chromatin leads to identification of small molecule mechanism of action.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chemical biology tools for studying histone post-translational modifications.Cell chemical biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Proximity labeling typically identifies interactomes of single protein or RNA baits, limiting its use for mechanisms distributed across molecular systems. Here, we establish MesoMap, a chromatin-focused mesoscale proximity-labeling strategy that installs nanoscale photocatalysts on multiple histone baits to monitor drug-induced redistribution of proteins near chromatin. MesoMap captured HDAC inhibitor-induced remodeling of chromatin-associated proteins and, in a proof-of-concept de-orphaning application, prioritized a chromatin-proximal CLK/splicing axis for SR-1815, a phenotypically discovered SynGAP-restoring small molecule. Integration with kinase assays, splicing analysis, inhibitor comparisons, and published neuronal validation supports a model in which SR-1815 regulates SynGAP abundance through polypharmacological kinase modulation, including CLK-dependent effects on splicing. Together, these studies establish MesoMap as a complementary approach for resolving drug-induced protein redistribution near chromatin and accelerating mechanism-of-action studies for phenotypic chemical probes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.